CONTACT: DAVE PEDERSEN
283 Medical Laboratories
Iowa City IA 52242
(319) 335-8032; fax (319) 335-8034
Wallace to step down as UI Cancer Center director; Weiner named interim
IOWA CITY, Iowa -- Robert B. Wallace, M.D., director of the University
of Iowa Cancer Center, will resign that position effective Aug. 1. Wallace's
resignation was accepted by Robert P. Kelch, M.D., dean of the UI College
of Medicine, and R. Edward Howell, chief executive officer of UI Hospitals
and Clinics, both of whom expressed appreciation for Wallace's contributions
to the center.
"Dr. Robert Wallace has had a major impact on our cancer center,"
Howell said. "The cancer center has made significant progress under
Kelch echoed Howell's sentiments, saying, "Bob Wallace has been
an outstanding administrator. The college and the hospital have benefited
from his leadership."
Wallace will remain a member of the faculty in the departments of internal
medicine and preventive medicine and environmental health. He will continue
to conduct his research on breast cancer, aging and clinical preventive
Wallace came to the UI in 1972. He was appointed head of the Department
of Preventive Medicine and Environmental Health in 1986, and was named
director of the UI Cancer Center in 1994.
He received his medical degree from Northwestern University and taught
at Emory University and the State University of New York at Buffalo before
coming to the UI.
The college announced that George J. Weiner, M.D., associate professor
of internal medicine, will begin as interim director of the UI Cancer Center
Aug. 1 while a nationwide search for a permanent director is conducted.
Weiner serves as deputy director of the cancer center and is a member of
the UI graduate program in immunology. He has served as associate director
for education at the cancer center, as well as director of the Hematology-Oncology
Fellowship Program in internal medicine.
A UI faculty member since 1989, Weiner received his medical degree from
Ohio State University and his oncology training at the University of Michigan.
His clinical interests include medical oncology and hematology with an
emphasis on the treatment of lymphoma (cancers of the lymphatic system)
and leukemia. His research interests include the use of monoclonal antibodies
as diagnostic tools and as agents to attack cancer cells.
The UI Cancer Center is nationally known for its cancer research, cancer
information service, and institutional and community-based cancer care
programs. It includes the John and Mary Pappajohn Clinical Cancer Center,
which opened in 1993.